trending Market Intelligence /marketintelligence/en/news-insights/trending/yE4ulBHhzzyrrbNkMMX5DA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Histogenics appoints EVP/COO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Histogenics appoints EVP/COO

Histogenics Corp. named Stephen Kennedy as executive vice president and COO of the company.

Kennedy was promoted from his previous role as the company's chief technology officer.